Acquisition of a Clinical Research Organization (CRO) company

Buy a Clinical Research Organization (CRO)

The acquired company is a CRO headquartered in Croatia with a strong regional presence across Central and Eastern Europe.
The company specializes in Phase II–IV clinical trials and offers a comprehensive suite of regulatory services to pharma, biotech, and medical device companies.
The buyer is ProPharma, the world’s largest RCO (Research Consulting Organization), which acquires and integrates CROs globally to expand its service offering and footprint.
CFIE business acquisition input: The CFIE M&A team conducted a targeted yet extensive outreach campaign. Hundreds of CROs were screened, analyzed, and approached. Clinres Farmacija was identified as a strong strategic fit for ProPharma through CFIE’s proprietary database and expert outreach.

Overview of a transaction of a clinical research organization

The acquired company, Clinres Farmacija, has been active in the CRO space since 2004. With deep operational roots in Central and Eastern Europe, it has built a solid reputation for delivering high-quality clinical trial and regulatory services. The company has long-standing client relationships and a strong track record of repeat business, which reflects its commitment to excellence. The combination of deep local market knowledge and experienced teams made Clinres Farmacija an ideal platform for further regional growth under a larger international organization.

The strategy of the CRO buyer

The buyer, ProPharma, is an international research consulting organization that supports biotech, med device, and pharmaceutical clients throughout the entire product lifecycle. ProPharma is actively expanding its capabilities and global reach through the acquisition of high-quality service providers across regions. The company’s strategic goal is to offer a fully integrated suite of consulting and clinical services worldwide. Through this acquisition, ProPharma strengthens its clinical trial delivery capacity in Central and Eastern Europe. Its broader activity focus includes:

Regulatory sciences
Clinical research solutions
Pharmacovigilance and compliance
Medical information and R&D technology

Activities of the CFIE M&A team in the support of acquiring this clinical research company

CFIE’s Pharma M&A team was instrumental in the identification and execution of this transaction. The team carried out a structured and highly targeted outreach campaign across the European CRO landscape. Using its robust internal database and strong industry reputation, CFIE approached a curated selection of high-potential targets. After engaging with the management of Clinres Farmacija, CFIE facilitated in-depth discussions between both parties. Throughout the process, CFIE provided strategic and transactional support to ensure a successful outcome for both the buyer and the seller.

Highlights of the acquisition of this clinical research company

Both companies are active in the life sciences sector and share a commitment to excellence in clinical trial execution and regulatory support
The acquisition allows ProPharma to strengthen its presence in Central and Eastern Europe, a region of strategic importance for clinical operations
Clinres Farmacija can benefit from ProPharma’s global infrastructure and expand its service offering to new and existing clients
ProPharma is well-positioned to invest further in the acquired company to drive growth and integration within its global platformInformation about business sales and acquisitions in the Dutch services industry

Feel free to contact us for further details about this managed services acquisition. If you are looking for acquisitions or business sales of pharmaceutical companies in other European countries it is also good to contact us. We know many pharma targets across Europe and some of these could be open for a sale. Please get in touch via the contact form at the bottom of this page so we can explain how we can help you in the area of managed services acquisitions or business sales.